Почетна › Хемофилија › Mičigen
Kliničke studije za Хемофилија u državi Mičigen
7 studija za Хемофилија traži učesnike na lokacijama u državi Mičigen.
Gradovi u državi Mičigen
Zvanični tekst studije (na engleskom)
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- University of Michigan - 1500 E Medical Center Dr, Ann Arbor
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07416604A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- University of Michigan Health System - Ann Arbor- Site Number : 8400003, Ann Arbor
Тражи се учесникФаза 3
Узраст од 1 до 11 · Мушкарци · Ажурирано 27. 10. 2026. · NCT07285460ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Central Michigan Children's Hospital of Michigan, Detroit
- Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 17. 8. 2026. · NCT04398628Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Children's Hospital of Michigan, Detroit
Тражи се учесникОпсервациона студија
Узраст од 6 до 19 · Оба пола · Ажурирано 2. 7. 2026. · NCT05022459A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- University of Michigan Hospitals - Michigan Medicine, Ann Arbor
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 60 · Оба пола · Ажурирано 2. 7. 2026. · NCT06349473Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- University of Michigan Medical School, Ann Arbor
- Central Michigan University: Children's Hospital of Michigan, Mount Pleasant
Тражи се учесникФаза 1
Узраст од 0 до 90 · Оба пола · Ажурирано 3. 4. 2026. · NCT05500807SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
- MSU Center for Bleeding and Clotting Disorders, Lansing
Тражи се учесникФаза 4
Узраст од 12 до 100 · Оба пола · Ажурирано 12. 1. 2026. · NCT04647227Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.